Use of Extracorporeal Photopheresis in Kidney Transplantation: Effects on Antibody-Mediated Rejection
NCT07663669 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 31
Last updated 2026-06-29
Summary
This study aims to describe, over a one-year period, the clinical, biological, and histological evolution of a cohort of kidney transplant recipients who developed antibody-mediated rejection and were treated with extracorporeal photopheresis.
Conditions
- Antibody-mediated Rejection in Kidney Transplant
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Besancon
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-30
- Primary Completion
- 2026-10-31
- Completion
- 2026-10-31
Countries
- France
Study Locations
More Related Trials
-
Safety and Efficacy of BiTE in Desensitization Therapy for Highly Sensitized Kidney Transplant Candidates With cPRA ≥ 90%
NCT07689149 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Immuno-humoral Rejection Markers in Pulmonary Transplant
NCT01791166 ·Status: COMPLETED ·Phase: NA
-
Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.
NCT01824368 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Biomarkers in Transplant Recipients to Improve Outcomes
NCT01163578 ·Status: RECRUITING
-
Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab
NCT07006532 ·Status: RECRUITING ·Phase: NA
-
Cell-based Assays for Antibody-mediated Transplant Rejection
NCT03916822 ·Status: UNKNOWN
-
Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host Disease
NCT00048789 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE)
NCT04803058 ·Status: TERMINATED ·Phase: PHASE2
-
Influence of Thymoglobuline on Phenotypic and Functional Profiles of B Lymphocytes in Renal Transplant Recipients
NCT02894606 ·Status: COMPLETED
-
Covid-19 Vaccine Response in Heart Transplant Recipients
NCT05268679 ·Status: COMPLETED
-
Comparison Between Bortezomib and Rituximab Plus Plasmapheresis in AMR
NCT03737136 ·Status: COMPLETED ·Phase: NA
-
Thymoglobulin Induction in Kidney Transplant Recipients
NCT01239563 ·Status: UNKNOWN ·Phase: PHASE3
-
Treatment Chronic UTI Post Kidney Transplant
NCT05967130 ·Status: TERMINATED ·Phase: PHASE3
-
B-Cell Targeted Carfilzomib Desensitization
NCT02442648 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Efficacy of the Bispecific T-Cell Engager (BiTE) in Kidney Transplant Recipients With Chronic Active Antibody-Mediated Rejection
NCT07689578 ·Status: RECRUITING ·Phase: PHASE4
-
The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT
NCT06362967 ·Status: RECRUITING ·Phase: PHASE2
-
PD-1 Antibody for Reactive EBV After BMT
NCT04690036 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation
NCT02812290 ·Status: RECRUITING
-
A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients.
NCT00275717 ·Status: COMPLETED
-
Tolerance Through Mixed Chimerism (Sip-Tego)
NCT06972069 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Study of Anti-BKPyV Immune Responses in Kidney Transplant Patients With BKPyV Viremia
NCT06988072 ·Status: NOT_YET_RECRUITING
-
Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant
NCT00063648 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Thymoglobulin Versus Basiliximab on Regulatory T Cell Function in Live Donor Kidney Transplant Recipients
NCT02730715 ·Status: TERMINATED
-
Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients
NCT01336296 ·Status: COMPLETED ·Phase: PHASE4
-
(TNX-1500) in Kidney Transplant Recipients
NCT07204080 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2